Superoxide dismutase activity of the salicylate-iron complex

Archives of Medical Research

Volumn 30, Issue 2, 1999, Pages 93-96

  Jay, David ^a   Jay, Elizabeth G ^a   Medina, Miguel Angel ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Anti inflammatory drugs; Iron; Oxidative injury; Salicylate; Superoxide dismutase; Superoxide radical

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; IRON COMPLEX; SALICYLIC ACID DERIVATIVE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; OXIDATIVE STRESS;

AEROBIOSIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CATALYSIS; FREE RADICALS; HYDROXYL RADICAL; IRON; NITROBLUE TETRAZOLIUM; SALICYLATES; SUPEROXIDE DISMUTASE; XANTHINE;

EID: 0033024480     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-0128(98)00024-4     Document Type: Article

References (27)

1. Goodwin S.J. Anti-inflammatory drugs. Stites P.D., Terr I.A., Parlow T.G. Basic & clinical immunology. 1994;Appleton and Lange, Norwalk, CT. 786.p.
2. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol. 231:1971;232.
3. Bannwarth B., Demotes-Mainard F., Schaeverbe ke T., Dehais J. Where are peripheral analgesics acting? Ann Rheum Dis. 52:1993;1.
4. Sagone A.L., Husney R.M. Oxidation of salicylates by stimulated granulocytes. evidence that these drugs act as free radical scavengers in biological systems J Immunol. 138:1987;2177.
5. Betts W.H., Cleland L.G. Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid. Arthritis. 25:1982;1469.
6. Powell S.R. Salicylate trapping of ̇OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart. Free Rad Res. 21:1994;355.
7. Korytowski W., Sarna T. Bleaching of melanin pigments. Role of copper ions and hydrogen peroxide in autooxidation and photooxidation of synthetic dopa-melanin. J Biol Chem. 265:1990;12410.
8. Halliwell B. How to characterize a biological antioxidant. Free Rad Res Commun. 9:1990;1.
9. 2 production by chelating copper Arch Biochem Biophys. 290:1991;463.
10. Jay D., Cuéllar A., Jay E., García C., Gleason R., Muñoz E. Study of a Fenton type reaction. effect of captopril and chelating reagents Arch Biochem Biophys. 298:1992;740.
11. Weglicki W.B., Mak T.I. Antioxidant drug mechanism. transition metal binding and vasodilation Mol Cell Biochem. 118:1992;105.
12. Jay D., Cuéllar A., Jay E. Superoxide dismutase activity of captopril-iron complex. Mol Cell Biochem. 146:1995;45.
13. Nishikimi M., Rao N.A., Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 46:1972;849.
14. Rabani J., Klug R.D., Lilie J. Pulse radiolytic investigation of the catalyzed disproportionation of peroxy radicals. Aqueous cupric ions. J Physiol Chem. 77:1973;1169.
15. 2+-chelates studied by pulse radiolysis. FEBS Lett. 47:1974;72.
16. Lumsden J., Hall D.O. Chloroplast manganese and superoxide. Biochem Biophys Res Commun. 64:1975;595.
17. Halliwell B. The superoxide dismutase activity of iron complexes. FEBS Lett. 56:1975;34.
18. Winterbourn C.C. Facts that influence the deoxyribose oxidation assay for Fenton reaction products. Free Rad Biol Med. 11:1991;353.
19. Scheneck P., Schneider S., Miehlke R., Prehm P. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J Rheumatol. 22:1995;400.
20. Kawasaki N., Tanimoto T., Tanaka A., Hayakawa T., Miyasaka N. Determination of non-protein-bound iron in human synovial fluid by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl. 656:1994;436.
21. Rowley D.A., Halliwell B. Formation of hydroxyl radicals from hydrogenperoxide and iron salts by superoxide- and ascorbate-dependent mechanisms. relevance to the pathology of rheumatoid disease Clin Sci. 64:1983;649.
22. Halliwell B., Gutteridge J.M., Blake D. Metal ions and oxygen radical reactions in human inflammatory joint disease. Philos Trans R Soc Lond B Biol Sci. 311:1985;659.
23. Biemond P., Swaak A.J., van Eijk H.G., Koster J.F. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Rad Biol Med. 4:1988;85.
24. Halliwell B., Hoult J.R., Blake D.R. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J. 2:1988;2867.
25. Saari H., Sorsa T., Konttinen Y.T. Reactive oxygen species and hyaluronate in serum and synovial fluid in arthritis. Int J Tissue React. 12:1990;81.
26. Benoni G, Cuzzoli L, Zambreri D, Caramazza I, Del Soldato P, Caliceti P, Conforti A. Desferrioxamine potentiated SOD antiinflammatory activity in rat adjuvant arthritis: role of iron and bacterial toxins. Agents Actions 1992;Spec. No:C112.
27. Allen R.E., Outhwaite J.M., Morris C.J., Blake D.R. Xanthine oxidoreductase is present in human synovium. Ann Rheum Dis. 46:1987;843.